QIAstat-Dx solutions and syndromic tests are available in over 100 countries globally
Qiagen has introduced an improved version of its QIAstat-Dx Respiratory SARS-CoV-2 Panel in Malaysia, following approval by the Medical Device Authority (MDA).
This new version, which holds a CE-IVD mark, increases its detection capability from 22 to 23 pathogens and is compatible with the QIAstat-Dx Rise system, a high-capacity variant of the QIAstat-Dx automated syndromic system.
This upgraded panel is a multiplexed nucleic acid real-time PCR test designed for the qualitative…
